MENU
+Compare
HYPMY
Stock ticker: OTC
AS OF
Nov 21 closing price
Price
$4.61
Change
-$0.24 (-4.95%)
Capitalization
3.02B

HYPMY Hypera SA Forecast, Technical & Fundamental Analysis

Hypera SA is a specialty and generic drug manufacturing company... Show more

HYPMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for HYPMY with price predictions
Nov 21, 2025

Aroon Indicator for HYPMY shows an upward move is likely

HYPMY's Aroon Indicator triggered a bullish signal on November 21, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 248 similar instances where the Aroon Indicator showed a similar pattern. In of the 248 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

HYPMY moved above its 50-day moving average on October 27, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HYPMY crossed bullishly above the 50-day moving average on October 30, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HYPMY advanced for three days, in of 244 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for HYPMY moved out of overbought territory on November 19, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 71 cases where HYPMY's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on November 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on HYPMY as a result. In of 117 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HYPMY turned negative on November 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 60 similar instances when the indicator turned negative. In of the 60 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HYPMY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HYPMY broke above its upper Bollinger Band on November 18, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.270) is normal, around the industry mean (17.139). P/E Ratio (18.989) is within average values for comparable stocks, (72.460). HYPMY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.930). Dividend Yield (0.045) settles around the average of (0.030) among similar stocks. P/S Ratio (2.248) is also within normal values, averaging (52.518).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HYPMY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HYPMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
HYPMY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

HYPMY paid dividends on January 12, 2023

Hypera SA HYPMY Stock Dividends
А dividend of $0.06 per share was paid with a record date of January 12, 2023, and an ex-dividend date of December 29, 2022. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
Avenida Magalhaes de Castro, 4800
Phone
N/A
Employees
10301
Web
https://www.hypermarcas.com.br
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JRACX82.100.37
+0.45%
Janus Henderson Research C
FTDZX184.72N/A
N/A
Franklin Biotechnology Discovery Adv
MLNIX26.27N/A
N/A
Morgan Stanley Instl Glbl Concntr I
CSMEX24.93N/A
N/A
Carillon Scout Mid Cap A
LAFLX14.88N/A
N/A
Lord Abbett Focused Large Cap Value A

HYPMY and Stocks

Correlation & Price change

A.I.dvisor tells us that HYPMY and PLNH have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYPMY and PLNH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPMY
1D Price
Change %
HYPMY100%
-4.95%
PLNH - HYPMY
21%
Poorly correlated
+7.11%
CPIX - HYPMY
20%
Poorly correlated
+3.93%
GLASF - HYPMY
20%
Poorly correlated
+13.26%
KMDA - HYPMY
20%
Poorly correlated
+0.60%
JUSHF - HYPMY
18%
Poorly correlated
+20.71%
More

Groups containing HYPMY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPMY
1D Price
Change %
HYPMY100%
-4.95%
Pharmaceuticals: Generic
industry (214 stocks)
11%
Poorly correlated
+1.55%